Navigation Links
PharmAthene Reports Third Quarter 2011 Financial and Operating Results
Date:11/9/2011

rsuant to an opinion issued September 22, 2011 from the Delaware Court of Chancery, PharmAthene is entitled to 50% of the net profits over 10 years from all sales of SIGA Technologies' ST-246, a novel smallpox antiviral agent being developed by SIGA for the treatment and prevention of morbidity and mortality associated with exposure to the causative agent of smallpox, and related products, once SIGA receives the first $40 million in net profits from sales of ST-246.  For more information about PharmAthene, please visit www.PharmAthene.com.

Statement on Cautionary Factors Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; "will"; "project"; "potential"; or similar statements are forward-looking statements. PharmAthene disclaims any intent or obligation to update these forward-looking statements other than as required by law. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manu
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. PharmAthene Progresses Second Generation rPA Anthrax Vaccine
2. PharmAthene Appoints Brian A. Markison to the Companys Board of Directors
3. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
4. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
5. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
6. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
7. PharmAthene Completes $6.5 Million Registered Direct Offering
8. PharmAthene Reports First Quarter 2011 Financial and Operating Results
9. PharmAthene to Host Year-End 2010 Earnings Conference Call and Webcast on Monday, March 28, 2011
10. PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
11. PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... research platform uses a laser to measure ... stress and heating, an approach likely to ... and batteries., This new technique, called nanomechanical ... and the surface stress of microscale structures ... the merits of surface-stress influence on mechanical ...
(Date:8/28/2014)... 2014  Next month, executives from clinical trial marketing firm ... beginning with Patient-Centered Clinical Trials 2014 , to be ... , September 4-5. Patient recruitment experts Bonnie A. ... will share insights on the benefits of employing an ... – from media to mobile apps – can be used ...
(Date:8/28/2014)... Fla. Exciting new work by a Florida State ... system that can take your temperature, emit white light, ... And, the molecule looks like a butterfly. , Biwu ... Biomedical Engineering in the FAMU-FSU College of Engineering, created ... but has continued to discover that his creation has ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 PrimeSource ... construction materials, selected SoundConnect to support ... cloud based audio and web conferencing platform GlobalMeet ... support PrimeSource’s employees’ needs. SoundConnect delivers award ... , PrimeSource Building Products will be utilizing ...
Breaking Biology Technology:New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3BBK Worldwide Leads Sessions at Key September Events 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2PrimeSource Chooses SoundConnect as Collaboration Provider 2
... Florida in mid-October. Late in the month, Florida Governor Jeb ... negotiations to create and pass a bill creating a $369 ... for the Scripts Research Institute to focus on biotechnology research ... an example of a state that successfully attracted a private ...
... university, an emerging biotech industry, a well educated work force ... has a $3.2 billion budget deficit and a per capita ... below the national average in citizens with a 4-year degree, ... states. The current state of our economy presents a complex ...
... took huge strides last week. In fact, the technology ... mortals might use in everyday communications. , ,What's driving ... executive board rooms to the stuff of ordinary communications? ... the availability of low-cost, high-quality desktop video cameras; and ...
Cached Biology Technology:Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies 2Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies 3Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies 4WARF Collaboration a Win-Win for Wisconsin 2WARF Collaboration a Win-Win for Wisconsin 3Video Conferencing for the Masses 2Video Conferencing for the Masses 3
(Date:8/31/2014)... fast and accurate tool to diagnose tuberculosis in ... developed test (TAM-TB assay) is the first reliable ... The test features excellent specificity, a similar sensitivity ... a blood test. The promising findings are a ... children, particularly in tuberculosis-endemic regions. , The study ...
(Date:8/31/2014)... busy attacking us, germs go after each other. But ... for the infected microbes: Sometimes viruses actually carry helpful ... its diet or better attack its own hosts. , ... system would robotically destroy anything it recognized as invading ... now revealed that one variety of the bacterial immune ...
(Date:8/31/2014)... diagnosis has changed very little. After taking a blood sample ... glass slide, stains it with a special dye, and looks ... disease. This approach gives an accurate count of how many ... disease severity but is not ideal because there is ... Singapore-MIT Alliance for Research and Technology (SMART) has now come ...
Breaking Biology News(10 mins):New tuberculosis blood test in children is reliable and highly specific 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 3A new way to diagnose malaria 2A new way to diagnose malaria 3
... perennial wheat to be grown on any significant basis in ... Texas Agricultural Experiment Station plant pathologist., From wheat producers ... is finding a groundswell of interest as he begins planting ... wheat study., Rush obtained his initial perennial wheat seed ...
... Barbara, Calif.) -- By peering deep into evolutionary history, ... discovered the origins of photosensitivity in animals. ... the scientific journal PLoS ONE. The scientists studied the ... animals that have existed for hundreds of millions of ...
... convene for two days in Germany, Oct. 18-19, to ... foster better economic and social conditions in Africa through ... pledged in the declarations of the Gleneagles and Heiligendamm ... development. About 70 experts from nine African nations, ...
Cached Biology News:A wheat for all seasons -- and reasons 2A wheat for all seasons -- and reasons 3UCSB researchers discover the dawn of animal vision 2Improving science, technology in Africa is aim as G-8, African, UN experts convene in Berlin 2Improving science, technology in Africa is aim as G-8, African, UN experts convene in Berlin 3
Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
... provides optimized blocking and wash solutions ... Ready-to-use wash solutions have been validated ... Slides for Microarrays (Product Code S ... 1L • Microarray Post Hybridization Wash ...
Biology Products: